EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Engineered plant extracellular vesicles: Emerging nanoplatforms for combinational cancer immunotherapy

Fucai Chen, Rongrong Bao, Wanyi Yang, Yijing Lu, Jiaxin Guo, Wenjing Chen, Jiale Li, Kuanhan Feng, Wen Zhang, Liuqing Di, Liang Feng, Ruoning Wang

Acta Pharmaceutica Sinica B · 2025-11 · 15 (11) · 5663-5701

DOI: 10.1016/j.apsb.2025.08.020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-11. Verfasst von Fucai Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 345 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Nanjing University of Chinese Medicine, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plant-derived extracellular vesicles (PDEVs), describe a group of nanoparticles released by plants. These particles are characterized by a lipid bilayer structure containing various proteins, lipids, nucleic acids, and unique metabolites. Although the study on PDEVs is relatively new, having only been around for ten years, they have shown promising development prospects in both basic research and clinical transformation areas. Evidence suggests that PDEVs have excellent application prospects in regulating inflammation and treating tumors. Their distinctive, vesicle-mimicking architecture and stellar biocompatibility render them prime candidates for ferrying various anti-cancer agents, including RNA, proteins, and conventional chemotherapy drugs. Increasingly, studies have shown that PDEVs can be engineered as an innovative platform for combination cancer immunotherapy. Consequently, this paper provides an extensive summary of current developments in engineering methods and strategies for PDEVs in cancer treatment and combined cancer immune therapeutics. The essential characteristics of PDEVs, including the biogenesis process and components, as well as their anti-tumor activity and mechanism, are summarized. Finally, the in vivo safety of PDEVs as delivery vectors and the challenges of scale-up production and clinical transformation are discussed.

Schlagwörter

Stichwörter der Autor:innen

Cancer immunotherapyClinical transformationCombinational cancer immunotherapyDrug loading techniquesEngineering strategiesNovel nanoplatformsPharmacokineticsPlant-derived extracellular vesicles

Autor:innen und Institutionen

  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Jiangsu Provincial TCM Engineering Technology Research Center of High Efficient Drug Delivery System, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Affiliated Jiangning Traditional Chinese Medicine Hospital, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

Förderung

  • National Natural Science Foundation of China
  • Nanjing University of Chinese Medicine
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Chen, F., Bao, R., Yang, W., Lu, Y., Guo, J., Chen, W., Li, J., Feng, K., Zhang, W., Di, L., Feng, L., & Wang, R. (2025). Engineered plant extracellular vesicles: Emerging nanoplatforms for combinational cancer immunotherapy. Acta Pharmaceutica Sinica B, 15(11), 5663-5701. https://doi.org/10.1016/j.apsb.2025.08.020

Vancouver

Chen F, Bao R, Yang W, Lu Y, Guo J, Chen W, et al. Engineered plant extracellular vesicles: Emerging nanoplatforms for combinational cancer immunotherapy. Acta Pharmaceutica Sinica B. 2025;15(11):5663-5701. doi:10.1016/j.apsb.2025.08.020

BibTeX
@article{Chen2025,
  author = {Chen, Fucai and Bao, Rongrong and Yang, Wanyi and Lu, Yijing and Guo, Jiaxin and Chen, Wenjing and Li, Jiale and Feng, Kuanhan and Zhang, Wen and Di, Liuqing and Feng, Liang and Wang, Ruoning},
  title = {Engineered plant extracellular vesicles: Emerging nanoplatforms for combinational cancer immunotherapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {5663--5701},
  doi = {10.1016/j.apsb.2025.08.020}
}
Kostenlos starten →